(HealthDay News) – A software monitoring program that tracks implantable cardioverter-defibrillator lead function could detect problems with the devices earlier than current monitoring processes.

SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an extravascular ICD system to treat tachycardia that may cause sudden cardiac arrest. Placing ...

World’s Only Completely Subcutaneous Implantable Defibrillator Provides Protection for Patients at Risk for Sudden Cardiac Arrest Without Touching the Heart SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter ...

Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest MARLBOROUGH, Mass., Boston Scientific Corporation has received FDA and CE Mark approval of the EMBLEM™ ...